Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | BRAF | P15056 | 14/20 | 0.48 |
| ▸ | KDR | P35968 | 4/20 | 0.48 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.45 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.45 |
| ▸ | KIT | P10721 | 1/20 | 0.45 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.45 |
| ▸ | FLT1 | P17948 | 1/20 | 0.45 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.45 |
| ▸ | TEK | Q02763 | 1/20 | 0.45 |
| ▸ | ESYT2 | A0FGR8 | 1/20 | 0.45 |
| ▸ | HACL2 | A1L0T0 | 1/20 | 0.45 |
| ▸ | NBAS | A2RRP1 | 1/20 | 0.45 |
| ▸ | GTPBP10 | A4D1E9 | 1/20 | 0.45 |
| ▸ | CNOT1 | A5YKK6 | 1/20 | 0.45 |
| ▸ | TBKBP1 | A7MCY6 | 1/20 | 0.45 |
| ▸ | AGPS | O00116 | 1/20 | 0.45 |
| ▸ | ACOT7 | O00154 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21943540 | 0.90 | BRAF (0.50) | LMNASMN1; SMN2BRAFKDRPDGFRB | |
| SCHEMBL21943411 | 0.89 | BRAF (0.53) | LMNASMN1; SMN2BRAFKDRPDGFRB | |
| SCHEMBL21943326 | 0.82 | LMNA (0.49) | LMNASMN1; SMN2BRAFKDRPDGFRB | |
| SCHEMBL21944061 | 0.82 | LMNA (0.51) | LMNASMN1; SMN2BRAFKDRPDGFRB | |
| SCHEMBL21944043 | 0.81 | BRAF (0.55) | LMNABRAFKDRPDGFRBFGFR1 | |
| SCHEMBL21943324 | 0.81 | LMNA (0.51) | LMNASMN1; SMN2BRAFKDRPDGFRB | |
| SCHEMBL21943762 | 0.79 | BRAF (0.57) | LMNABRAFKDRPDGFRBFGFR1 | |
| SCHEMBL21944046 | 0.79 | BRAF (0.66) | LMNABRAFKDRPDGFRBFGFR1 | |
| SCHEMBL21942995 | 0.78 | RAF1 (0.61) | LMNABRAFPDGFRBFGFR1NTRK1 | |
| SCHEMBL21943424 | 0.78 | BRAF (0.68) | LMNABRAFKDRPDGFRBFGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11319322-B2 | Substituted aryl ether compound, preparation method thereof, pharmaceutical composition and use thereof | XIAMEN UNIVERSITY (CN) | 2022-05-03 | — | — | US | disclosed |
| US-20200123162-A1 | SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | XIAMEN UNIVERSITY (CN) | 2020-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200123162-A1 | SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | CYP4A11, CYP2D6, CYP3A43 | LMNA 1474/4885SMN1; SMN2 3250/4885BRAF 95/4885 |
| US-11319322-B2 | Substituted aryl ether compound, preparation method thereof, pharmaceutical composition and use thereof | CYP4A11, CYP2D6, CYP3A43 | LMNA 1474/4885SMN1; SMN2 3250/4885BRAF 95/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.